Immunotherapy with engineered bacteria by targeting the STING pathway for anti-tumor immunity
出版年份 2020 全文链接
标题
Immunotherapy with engineered bacteria by targeting the STING pathway for anti-tumor immunity
作者
关键词
-
出版物
Nature Communications
Volume 11, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-06-01
DOI
10.1038/s41467-020-16602-0
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Engineered probiotics for local tumor delivery of checkpoint blockade nanobodies
- (2020) Candice R. Gurbatri et al. Science Translational Medicine
- An engineered E. coli Nissle improves hyperammonemia and survival in mice and shows dose-dependent exposure in healthy humans
- (2019) Caroline B. Kurtz et al. Science Translational Medicine
- Understanding Biological Regulation Through Synthetic Biology
- (2018) Caleb J. Bashor et al. Annual Review of Biophysics
- An overview on Vadimezan (DMXAA): The vascular disrupting agent
- (2018) Amir Daei Farshchi Adli et al. Chemical Biology & Drug Design
- Programming gene and engineered-cell therapies with synthetic biology
- (2018) Tasuku Kitada et al. SCIENCE
- Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria
- (2018) Vincent M Isabella et al. NATURE BIOTECHNOLOGY
- Magnitude of Therapeutic STING Activation Determines CD8+ T Cell-Mediated Anti-tumor Immunity
- (2018) Kelsey E. Sivick et al. Cell Reports
- Cutting Edge: Activation of STING in T Cells Induces Type I IFN Responses and Cell Death
- (2017) Bridget Larkin et al. JOURNAL OF IMMUNOLOGY
- Versatile modes of cellular regulation via cyclic dinucleotides
- (2017) Petya Violinova Krasteva et al. Nature Chemical Biology
- Inflammatory Signals Regulate IL-15 in Response to Lymphodepletion
- (2016) Scott M. Anthony et al. JOURNAL OF IMMUNOLOGY
- PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
- (2016) Weiping Zou et al. Science Translational Medicine
- Therapy of solid tumors using probiotic Symbioflor-2 – restraints and potential
- (2016) Dino Kocijancic et al. Oncotarget
- STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade
- (2015) Juan Fu et al. Science Translational Medicine
- Cancer Immunotherapy with Immunomodulatory Anti-CD137 and Anti-PD-1 Monoclonal Antibodies Requires BATF3-Dependent Dendritic Cells
- (2015) A. R. Sanchez-Paulete et al. Cancer Discovery
- Clostridium novyi-NT can cause regression of orthotopically implanted glioblastomas in rats
- (2015) Verena Staedtke et al. Oncotarget
- Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity
- (2015) Leticia Corrales et al. Cell Reports
- Trial Watch: Immunostimulation with Toll-like receptor agonists in cancer therapy
- (2015) Kristina Iribarren et al. OncoImmunology
- STING-Dependent Cytosolic DNA Sensing Mediates Innate Immune Recognition of Immunogenic Tumors
- (2014) Seng-Ryong Woo et al. IMMUNITY
- Single Nucleotide Polymorphisms of Human STING Can Affect Innate Immune Response to Cyclic Dinucleotides
- (2013) Guanghui Yi et al. PLoS One
- The Innate Immune DNA Sensor cGAS Produces a Noncanonical Cyclic Dinucleotide that Activates Human STING
- (2013) Elie J. Diner et al. Cell Reports
- Construction and Application of aluxABCDEReporter System for Real-Time Monitoring of Enterococcus faecalis Gene Expression and Growth
- (2012) Sabina Leanti La Rosa et al. APPLIED AND ENVIRONMENTAL MICROBIOLOGY
- Escherichia coli Nissle 1917 Targets and Restrains Mouse B16 Melanoma and 4T1 Breast Tumors through Expression of Azurin Protein
- (2012) Yunlei Zhang et al. APPLIED AND ENVIRONMENTAL MICROBIOLOGY
- In Vivo Gene Expression Dynamics of Tumor-Targeted Bacteria
- (2012) Tal Danino et al. ACS Synthetic Biology
- MPYS Is Required for IFN Response Factor 3 Activation and Type I IFN Production in the Response of Cultured Phagocytes to Bacterial Second Messengers Cyclic-di-AMP and Cyclic-di-GMP
- (2011) L. Jin et al. JOURNAL OF IMMUNOLOGY
- Identification of tumor-specific Salmonella Typhimurium promoters and their regulatory logic
- (2011) Sara Leschner et al. NUCLEIC ACIDS RESEARCH
- Tumour Targeting with Systemically Administered Bacteria
- (2010) David Morrissey et al. CURRENT GENE THERAPY
- Translational Regulation of Gene Expression by an Anaerobically Induced Small Non-coding RNA in Escherichia coli
- (2010) Anders Boysen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Phagocytosis and Phagosome Acidification Are Required for Pathogen Processing and MyD88-Dependent Responses to Staphylococcus aureus
- (2010) W. K. E. Ip et al. JOURNAL OF IMMUNOLOGY
- Reprogramming of anaerobic metabolism by the FnrS small RNA
- (2010) Sylvain Durand et al. MOLECULAR MICROBIOLOGY
- Toll-like receptor agonists in cancer therapy
- (2009) Sylvia Adams Immunotherapy
- Drug-inducible remote control of gene expression by probiotic Escherichia coli Nissle 1917 in intestine, tumor and gall bladder of mice
- (2009) Holger Loessner et al. MICROBES AND INFECTION
- Tumor Invasion of Salmonella enterica Serovar Typhimurium Is Accompanied by Strong Hemorrhage Promoted by TNF-α
- (2009) Sara Leschner et al. PLoS One
- Development of a Listeria monocytogenes based vaccine against prostate cancer
- (2008) Vafa Shahabi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Containment of Tumor-Colonizing Bacteria by Host Neutrophils
- (2008) K. Westphal et al. CANCER RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started